One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Stage Classification and Prognosis Assessment in Localized Pancreatic Cancer: It Takes Two to Tango.
Milella, Michele MD 1,,
doi : 10.1200/JCO.23.02494
Volume 42(12) pgs. 1331-1457 April 20, 2024
Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer: We Must Do Better.
Mehtsun, Winta T. MD, MPH 1,; Gupta, Samir MD, MSCS 2,3,,
doi : 10.1200/JCO.23.02186
Use of External Control Cohorts in Pediatric Brain Tumor Clinical Trials.
Margol, Ashley S. MD, MS 1,,; Molinaro, Annette M. PhD 2; Onar-Thomas, Arzu PhD 3,; Resnick, Adam PhD 4; Hanson, Derek MD 5; Kieran, Mark MD, PhD 6,; Mishra-Kalyani, Pallavi PhD 7; Rivera, Donna PharmD 7; Barone, Amy MD 7; Arons, David JD 8; Meehan, Clair MEM 8; Prados, Michael MD 9,
doi : 10.1200/JCO.23.01084
Long-Term Follow-Up of the Anthracyclines in Early Breast Cancer Trials (USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 [NRG Oncology]).
Geyer, Charles E. Jr MD 1,2,,; Blum, Joanne L. MD, PhD 3,; Yothers, Greg PhD 4,; Asmar, Lina PhD 5; Flynn, Patrick J. MD 6,; Robert, Nicholas J. MD 7,; Hopkins, Judith O. MD 8; O'Shaughnessy, Joyce A. MD 9,; Rastogi, Priya MD 1,2,10; Puhalla, Shannon L. MD 1,2,; Hilton, Christie J. DO 1,11,; Dang, Chau T. MD 12,; Gomez, Henry Leonidas MD, MSc, PhD 13,; Vukelja, Svetislava J. MD 14; Lyss, Alan P. MD 15; Paul, Devchand DO, PhD 5; Brufsky, Adam M. MD, PhD 2,10,; Colangelo, Linda H. MS 4; Swain, Sandra M. MD 1,16,; Mamounas, Eleftherios P. MD 1,17,; Wolmark, Norman MD 1,2,
doi : 10.1200/JCO.23.01428
Overall Survival From the EORTC LCG-1613 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer.
Remon, Jordi MD, PhD 1,; Besse, Benjamin MD, PhD 1,; Aix, Santiago Ponce MD, PhD 2,; Callejo, Ana MD 3,; Al-Rabi, Kamal MD, PhD 4,; Bernabe, Reyes MD, PhD 5,; Greillier, Laurent MD, PhD 6,; Majem, Margarita MD, PhD 7,; Reguart, Noemi MD, PhD 8,; Monnet, Isabelle MD 9,; Cousin, Sophie MD, PhD 10; Garrido, Pilar MD, PhD 11,; Robinet, Gilles MD, PhD 12; Campelo, Rosario Garcia MD, PhD 13,; Madroszyk, Anne MD 14,; Mazieres, Julien MD, PhD 15,; Curcio, Hubert MD, PhD 16,; Wasag, Bartosz MD, PhD 17,; Pretzenbacher, Yassin PhD 18; Grillet, Fanny PhD 18; Dingemans, Anne-Marie C. MD, PhD 19,; Dziadziuszko, Rafal MD, PhD 17,
doi : 10.1200/JCO.23.01521
Improved Clinical Staging System for Localized Pancreatic Cancer Using the ABC Factors: A TAPS Consortium Study.
Dekker, Esther N. MD 1; van Dam, Jacob L. MD 1; Janssen, Quisette P. MD, PhD 1; Besselink, Marc G. MD, PhD 2,3,; DeSilva, Annissa MD 4; Doppenberg, Deesje MD 2,3; van Eijck, Casper H.J. MD, PhD 1,; Nasar, Naaz MD 5; O'Reilly, Eileen M. MD 6,; Paniccia, Alessandro MD 4,; Prakash, Laura R. MD 7; Tzeng, Ching-Wei D. MD 7,; Verkolf, Eva M.M. MD 1; Wei, Alice C. MD 5,; Zureikat, Amer H. MD 4; Katz, Matthew H.G. MD 7,; Groot Koerkamp, Bas MD, PhD 1,,; for the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium; Asmar, Rudy el; Haviland, Dana; Ilagan, Crisanta; McIntyre, Caitlin; McIntyre, Sarah; Stoop, Thomas F.; Theijse, Rutger T.
doi : 10.1200/JCO.23.01311
Racial Disparities in Receipt of Guideline-Concordant Care for Early-Onset Colorectal Cancer in the United States.
Nogueira, Leticia M. PhD, MPH 1,; May, Folasade P. MD 2,; Yabroff, K. Robin PhD 1,; Siegel, Rebecca L. MS 1
doi : 10.1200/JCO.23.00539
Patient-Specific Measurable Residual Disease Markers Predict Outcome in Patients With Myelodysplastic Syndrome and Related Diseases After Hematopoietic Stem-Cell Transplantation.
Tobiasson, Magnus MD, PhD 1,2,,; Pandzic, Tatjana PhD 3; Illman, Johanna MD 4; Nilsson, Lars MD, PhD 5; Westrom, Simone PhD 3; Ejerblad, Elisabeth MD, PhD 6; Olesen, Gitte MD, PhD 7,; Bjorklund, Andreas MD, PhD 8; Olsnes Kittang, Astrid MD, PhD 9,10,; Werlenius, Olle MD 11; Lorentz, Fryderyk MD 12; Rasmussen, Bengt MD 13; Cammenga, Jorg MD, PhD 5,14,; Weber, Duruta MD, PhD 15; Lindholm, Carolin MD 1,2; Wiggh, Joel MD 1,2,; Dimitriou, Marios PhD 2; Moen, Ann Elin 16; Yip Lundstrom, Laimei 17,; von Bahr, Lena MD, PhD 11,; Baltzer-Sollander, Karin 18,; Jadersten, Martin MD, PhD 1,2,; Kytola, Soili MD, PhD 19; Walldin, Gunilla 2; Ljungman, Per MD, PhD 8,; Groenbaek, Kirsten MD, PhD 20,; Mielke, Stephan MD, PhD 8,21,; Jacobsen, Sten Eirik W. MD, PhD 2; Ebeling, Freja MD, PhD 4,; Cavelier, Lucia PhD 18; Smidstrup Friis, Lone MD, PhD 20,; Dybedal, Ingunn MD, PhD 16,; Hellstrom-Lindberg, Eva MD, PhD 1,2
doi : 10.1200/JCO.23.01159
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2-Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II Clinical Trials.
Sheng, Xinan MD 1,; Wang, Lin MD 2; He, Zhisong MD 3; Shi, Yanxia MD 4; Luo, Hong MD 5; Han, Weiqing MD 6; Yao, Xin MD 7; Shi, Benkang MD 8; Liu, Jiyan MD 9; Hu, Changlu MD 10; Liu, Ziling MD 11; Guo, Hongqian MD 12; Yu, Guohua MD 13; Ji, Zhigang MD 14; Ying, Jianming MD 15; Ling, Yun MD 15; Yu, Shiying MD 16; Hu, Yi MD 17; Guo, Jianming MD 18; Fang, Jianmin PhD 19,20,; Zhou, Aiping MD 2,,; Guo, Jun MD 1,
doi : 10.1200/JCO.22.02912
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Milowsky, Matthew I. MD 1,,; O'Donnell, Peter H. MD 2,; Hoimes, Christopher J. DO 3,; Petrylak, Daniel P. MD 4,; Flaig, Thomas W. MD 5,; Moon, Helen H. MD 6,; Friedlander, Terence W. MD 7,; Mar, Nataliya MD 8,; McKay, Rana R. MD 9,; Srinivas, Sandy MD 10,; Gravis, Gwenaelle MD 11,; Ramamurthy, Chethan MD 12,; Bupathi, Manojkumar MD, MS 13,; Bracarda, Sergio MD 14,; Wright, Phoebe PharmD, MS 15,; Hepp, Zsolt PharmD, MS 15,; Carret, Anne-Sophie MD 15,; Yu, Yao PhD 15,; Dillon, Ryan MSc 16,; Kataria, Ritesh MD 17,; Beaumont, Jennifer L. MS 18,; Purnajo, Intan MPH 18; Rosenberg, Jonathan E. MD 19,
doi : 10.1200/JCO.23.01547
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3.
Grivas, Petros MD, PhD 1,,; Pouessel, Damien MD, PhD 2,; Park, Chandler H. MD 3,; Barthelemy, Philippe MD, PhD 4,; Bupathi, Manojkumar MD, MS 5,; Petrylak, Daniel P. MD 6,; Agarwal, Neeraj MD 7,; Gupta, Sumati MD 7,; Flechon, Aude MD, PhD 8,; Ramamurthy, Chethan MD 9,; Davis, Nancy B. MD 10,; Recio-Boiles, Alejandro MD, FACP 11,; Sternberg, Cora N. MD 12,; Bhatia, Astha MPH, DMD 13,; Pichardo, Cabilia MD 13,; Sierecki, Mitch MD 13,; Tonelli, Julia MD 13,; Zhou, Huafeng MD 13,; Tagawa, Scott T. MD, MS 12,; Loriot, Yohann MD, PhD 14,
doi : 10.1200/JCO.22.02835
Streptococcus salivarius K12 Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors: A Randomized Controlled Trial.
Peng, Xingchen MD 1; Li, Zixia MDS 2; Pei, Yiyan MM 1; Zheng, Shuhao DDS 2; Liu, Jinchi MDS 2; Wang, Jingjing MD 1; Li, Ruidan MD 1; Xu, Xin DDS 2,
doi : 10.1200/JCO.23.00837
Understanding Protective Mechanisms of an Oral Probiotic in Reducing Radiation-Induced Oral Mucositis.
Wardill, Hannah R. PhD 1,2,,; Bossi, Paolo MD, PhD 3,4,; Sonis, Stephen T. DMD, PhD 5,6,7,
doi : 10.1200/JCO.23.02706
KIT ATP-Binding Pocket/Activation Loop Mutations in GI Stromal Tumor: Emerging Mechanisms of Kinase Inhibitor Escape.
Muhlenberg, Thomas PhD 1,2; Falkenhorst, Johanna MD 1,2,; Schulz, Tom MSc 3,4; Fletcher, Benjamin S. BA 1,2; Teuber, Alina MSc 3,4; Krzeciesa, Dawid MSc 1,2; Klooster, Isabella MA 5; Lundberg, Meijun MD 5; Wilson, Lydia BSc 5; Lategahn, Jonas PhD 3,4,; von Mehren, Margaret MD 6,; Grunewald, Susanne PhD 1,2; Tuns, Alicia Isabell MSc 7; Wardelmann, Eva MD 8,; Sicklick, Jason K. MD 9,10,; Brahmi, Mehdi MD, PhD 11,; Serrano, Cesar MD, PhD 12,13,; Schildhaus, Hans-Ulrich MD 14,15,; Sievers, Sonja PhD 16; Treckmann, Jurgen MD 17; Heinrich, Michael C. MD 18,; Raut, Chandrajit P. MD, MSc 19,20,21; Ou, Wen-Bin PhD 5,22; Marino-Enriquez, Adrian MD, PhD 5; George, Suzanne MD 23,; Rauh, Daniel PhD 3,4,; Fletcher, Jonathan A. MD 5,; Bauer, Sebastian MD 1,2,,
doi : 10.1200/JCO.23.01197
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.
Burstein, Harold J. MD, PhD 1; DeMichele, Angela MD 2,; Fallowfield, Lesley DPhil 3,; Somerfield, Mark R. PhD 4; Henry, N. Lynn MD, PhD 5,; for the Biomarker Testing and Endocrine and Targeted Therapy in Metastatic Breast Cancer Expert Panels; Henry, N. Lynn MD, PhD; Dayao, Zoneddy MD; Elias, Anthony MD; Kalinsky, Kevin MD, MS; McShane, Lisa M. PhD; Moy, Beverly MD, MPH; Park, Ben Ho MD, PhD; Shanahan, Kelly M. MD; Sharma, Priyanka MD; Shatsky, Rebecca MD; Stringer-Reasor, Erica MD; Telli, Melinda MD; Turner, Nicholas C. MD, PhD; DeMichele, Angela MD; Burstein, Harold J. MD, PhD; Barton, Debra L. PhD, RN; Dorris, Ali MBA, MFA; Fallowfield, Lesley J. DPhil; Jain, Dharamvir MD; Johnston, Stephen R.D. MD, PhD; Korde, Larissa A. MD; Litton, Jennifer K. MD; Macrae, Erin R. MD; Peterson, Lindsay L. MD, MSCR; Vikas, Praveen MBBS; Yung, Rachel L. MD; Rugo, Hope S. MD
doi : 10.1200/JCO.24.00248
Efficiency of Biomarker-Driven Clinical Trial Designs.
Freidlin, Boris PhD; Korn, Edward L. PhD
doi : 10.1200/JCO.23.02581
Reply to B. Freidlin et al.
Lee, Choong-kun MD, PhD; Park, Sejung PhD; Nam, Chung Mo PhD; Chung, Hyun Cheol MD, PhD; Rha, Sun Young MD, PhD
doi : 10.1200/JCO.24.00012
Erratum: Effect of a Community Health Worker-Led Intervention Among Low-Income and Minoritized Patients With Cancer: A Randomized Clinical Trial.
doi : 10.1200/JCO.24.00286
Erratum: Pathologic Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes.
doi : 10.1200/JCO.24.00317
